Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger Thierry Bourguignon, MD, Rym El Khoury, MD, Pascal Candolfi, PhD, Claudia Loardi, MD, Alain Mirza, MD, Julie Boulanger-Lothion, MD, Anne-Lorraine Bouquiaux-Stablo-Duncan, MD, Fabien Espitalier, MD, Michel Marchand, MD, Michel Aupart, MD The Annals of Thoracic Surgery Volume 100, Issue 3, Pages 853-859 (September 2015) DOI: 10.1016/j.athoracsur.2015.03.105 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier estimates of overall (red) and valve-related survival with (blue) and without early death (green). The Annals of Thoracic Surgery 2015 100, 853-859DOI: (10.1016/j.athoracsur.2015.03.105) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan-Meier estimates of cumulative incidence of the following valve-related complications: thromboembolism (blue), bleeding events (maroon), and endocarditis (yellow). The Annals of Thoracic Surgery 2015 100, 853-859DOI: (10.1016/j.athoracsur.2015.03.105) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier estimates of freedom from reoperation (blue), structural valve deterioration (SVD; red), and explant as a result of structural valve deterioration (green). The expected valve durability (median survival time without structural valve deterioration) was 17.6 years. The Annals of Thoracic Surgery 2015 100, 853-859DOI: (10.1016/j.athoracsur.2015.03.105) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Competing risk analysis—cumulative risk of valve explantation (green) and death (red). Event-free survival is shown in blue. The Annals of Thoracic Surgery 2015 100, 853-859DOI: (10.1016/j.athoracsur.2015.03.105) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions